Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 October 2018
Geologist shares ground-breaking findings at Alex du Toit lecture
From the left: Prof Marian Tredoux, Associate Professor in the UFS Department of Geology, Prof Lew Ashwal, and Snegugu Zigubu, BSc (Hons) Geology student.

The Department of Geology at the University of the Free State (UFS) was recently the host of a lecture in the 2018 Alex du Toit Memorial Lecture series.

The speaker at this event was the A-rated NRF researcher, Prof Lew Ashwal from the University of the Witwatersrand. He addressed academics and geology students on ‘Wandering continents of the Indian Ocean’.

Lost continent found


In this talk he specifically shared the research he conducted on the islands of Madagascar (which he visited 30 times to conduct field work and says it is not for the faint-hearted), the Seychelles, and Mauritius. 

Two things stood out in his lecture: the way in which his findings on the three islands helped to refine details about the assembly of the Gondwana supercontinent, and the report of a ‘lost continent’ found under Mauritius. 

These discussions were linked by Prof Ashwal’s belief that the so-called lost continent he found under Mauritius is a leftover from the break-up of Gondwana,

The discovery was made when he and a team of researchers found zircon from 2000 million years ago on a 9-million-year-young island. He believes that the piece of crust (where the tested zircon probably formed), which was covered by lava during recent volcanic eruptions on the island, is a tiny piece of the ancient continent which broke off from Madagascar, when Africa, India, Australia and Antarctica split up and formed the Indian Ocean.

Media frenzy 

The fact that the team of researchers found these extremely old minerals proves that there are materials under Mauritius that originated from a continent under the island. 

Prof Ashwal is studying the break-up process of the continents in order to understand the geological history of the planet.

For his work Prof Ashwal has enjoyed coverage from publications as far apart in focus from each other as The New York Times and Cosmopolitan magazine. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept